693 related articles for article (PubMed ID: 34696334)
21. Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients.
Stattin K; Lipcsey M; Andersson H; Pontén E; Bülow Anderberg S; Gradin A; Larsson A; Lubenow N; von Seth M; Rubertsson S; Hultström M; Frithiof R
J Crit Care; 2020 Dec; 60():249-252. PubMed ID: 32920503
[TBL] [Abstract][Full Text] [Related]
22. Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections.
Al-Horani RA
Am J Cardiovasc Drugs; 2020 Dec; 20(6):525-533. PubMed ID: 32918208
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis, management, and outcomes of venous thromboembolism in COVID-19 positive patients: a role for direct anticoagulants?
Kartsios C; Lokare A; Osman H; Perrin D; Razaq S; Ayub N; Daddar B; Fair S
J Thromb Thrombolysis; 2021 May; 51(4):947-952. PubMed ID: 32910408
[TBL] [Abstract][Full Text] [Related]
24. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
25. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
Gando S; Wada T
Front Immunol; 2021; 12():649122. PubMed ID: 34177896
[TBL] [Abstract][Full Text] [Related]
26. Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?
Papadaki S; Tselepis AD
Angiology; 2019 Nov; 70(10):896-907. PubMed ID: 31010298
[TBL] [Abstract][Full Text] [Related]
27. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
28. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
[TBL] [Abstract][Full Text] [Related]
29. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
[TBL] [Abstract][Full Text] [Related]
30. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
[TBL] [Abstract][Full Text] [Related]
31. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
Langer F; Kluge S; Klamroth R; Oldenburg J
Hamostaseologie; 2020 Aug; 40(3):264-269. PubMed ID: 32498097
[TBL] [Abstract][Full Text] [Related]
32. Thromboinflammation in COVID-19 acute lung injury.
Mitchell WB
Paediatr Respir Rev; 2020 Sep; 35():20-24. PubMed ID: 32653469
[TBL] [Abstract][Full Text] [Related]
33. COVID-19-induced coagulopathy: Experience, achievements, prospects.
Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
[TBL] [Abstract][Full Text] [Related]
34. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
[TBL] [Abstract][Full Text] [Related]
35. Alteraciones de la coagulación en la COVID-19.
Carrillo-Esper R; Melgar-Bieberach RE; Jacinto-Flores SA; Tapia-Salazar M; Campa-Mendoza ÁN
Cir Cir; 2020; 88(6):787-793. PubMed ID: 33254192
[TBL] [Abstract][Full Text] [Related]
36. COVID-19-related laboratory coagulation findings.
Devreese KMJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
[TBL] [Abstract][Full Text] [Related]
37. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
38. Severe arterial thromboembolism in patients with Covid-19.
Lameijer JRC; van Houte J; van Berckel MMG; Canta LR; Yo LSF; Nijziel MR; Krietemeijer GM; Troquay SAM; Buise MP; Hendriks J
J Crit Care; 2020 Dec; 60():106-110. PubMed ID: 32799178
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of sepsis-induced coagulopathy : Results of a Germany-wide survey in intensive care units].
Schmoch T; Brenner T; Becker-Pennrich A; Hinske LC; Weigand MA; Briegel J; Möhnle P;
Anaesthesist; 2021 Aug; 70(8):662-670. PubMed ID: 33558944
[TBL] [Abstract][Full Text] [Related]
40. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
